Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 9Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Sarcoma 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Sarcoma, Kaposi 1Pinealoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Muscle Invasive Bladder Urothelial Carcinoma 1Motor Activity 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Liver Neoplasms 1Laryngeal Diseases 1Hodgkin Disease 1Glioma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Borderline Resectable Pancreatic Adenocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Radiotherapy, Intensity-Modulated 1Nivolumab 1Metformin 1Ipilimumab 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Laryngeal Diseases × Nivolumab × Clear all
NCT03162731 2025-04-29

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
24 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡